当前位置: 首页 >> 检索结果
共有 38350 条符合本次的查询结果, 用时 1.3775375 秒

81. Deep Learning-Enhanced Noninvasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization.

作者: Zhihua Huang.;Xiaolin Diao.;Yanni Huo.;Zhihui Zhao.;Jiahui Geng.;Qing Zhao.;Jia Liu.;Qunying Xi.;Yun Xia.;Ou Xu.;Xin Li.;Anqi Duan.;Sicheng Zhang.;Luyang Gao.;Yijia Wang.;Sicong Li.;Qin Luo.;Zhihong Liu.;Wei Zhao.
来源: Chest. 2025年
Pulmonary hypertension (PH) is a complex, life-threatening condition requiring noninvasive, accessible, and accurate diagnostic tools, particularly in resource-limited settings. Early and precise identification of PH and its subtypes is critical for effective management and timely intervention.

82. Timing of Screening Benefit for Lung Cancer With Low-Dose CT Imaging.

作者: Yang Xie.;Yiyin Zhang.;Peng Zhang.;Yiting Li.;Baichuan Xu.;Fang Shao.;Yingying Zhang.;Tian Yang.;Jiansheng Li.;Chao Li.;Tao Chen.
来源: Chest. 2025年
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.

83. Combined Interstitial Features and Emphysema in National Lung Screening Trial Participants: Prognostic Implications.

作者: Hyungjin Kim.;Seung Ho Choi.;Christopher J Ryerson.;Peter M George.;Jin Mo Goo.
来源: Chest. 2025年

84. Pleural Fluid Analysis: Maximizing Diagnostic Yield in the Pleural Effusion Evaluation.

作者: Amit Chopra.;Kurt Hu.;David Feller-Kopman.;Marc A Judson.
来源: Chest. 2025年
Establishing the cause of a pleural effusion can be challenging. Analysis of pleural fluid (PF) is a powerful tool to determine the cause of a pleural effusion. Surprisingly, despite the diagnostic power of PF analysis (PFA), it is often underused. This review provides a practical framework to maximize the diagnostic potential of the PFA. We describe the role of a PFA in establishing the cause of a pleural effusion. We also discuss challenges and limitations of PFA.

85. Pulmonary Subsolid Nodules: Watchful Waiting, Not Upfront Surgery May Be a Better Strategy?

作者: Rirong Qu.;Xiangning Fu.
来源: Chest. 2025年167卷6期e207页

86. Response.

作者: Fenglan Li.;Linlin Qi.;Jianwei Wang.
来源: Chest. 2025年167卷6期e207-e210页

87. Response.

作者: Marcin Waligóra.;Grzegorz Kopeć.
来源: Chest. 2025年167卷6期e206页

88. Beta-Blockers in Pulmonary Arterial Hypertension: Still an Evidence Gap.

作者: Stavros Dimopoulos.;Christos Kourek.;Serafim Nanas.
来源: Chest. 2025年167卷6期e205-e206页

89. Transesophageal Echocardiography and Transesophageal Lung Ultrasound Guided Positive End-Expiratory Pressure Recruitment Maneuver in a Patient With Obesity Requiring Venovenous Extracorporeal Membrane Oxygenation.

作者: Matthew Federbush.;Dae Hyeon Kim.;Paul H Mayo.
来源: Chest. 2025年167卷6期e201-e203页

90. A 54-Year-Old Woman With Recurrent Exertional Dyspnea After Surgical Repair for Atrial Septal Defect.

作者: Jiajun Guo.;Juan He.;Shichu Liang.;Yucheng Chen.
来源: Chest. 2025年167卷6期e195-e199页
A 54-year-old woman with a history of recurrent exertional dyspnea for 5 years was admitted for evaluation. Six months prior, she noted a worsening of her symptoms, with progressive physical activity limitation caused by exertional fatigue and dyspnea (climbing 2 to 3 flights of stairs). She also experienced palpitations, with an estimated heart rate that ranged from 120 to 150 beats per minute. The patient denied chest pain, hemoptysis, or other notable symptoms. Notably, the patient underwent surgical repair of an atrial septal defect more than 20 years earlier, with a good postoperative recovery. Regular postoperative echocardiograms revealed no residual shunt, no valvular abnormalities, and no pulmonary hypertension. The patient had no history of smoking, drug abuse, or alcohol consumption.

91. An Older Adult Man With a Massive Pleural Effusion.

作者: Wesley Teck Wee Loo.;Sandra Li Yan Hui.
来源: Chest. 2025年167卷6期e189-e194页
A 94-year-old man presented with a 1-day history of dyspnea and no infective symptoms. There was no associated chest pain, cough, or fever. Systemic review was negative for loss of appetite or weight. He had a medical history of ischemic heart disease with an ejection fraction of 45%, hypertension, hyperlipidemia, and Alzheimer dementia.

92. A 47-Year-Old Woman With Recurrent Fever and Productive Cough.

作者: Lingjian Wang.;Xin Sun.;Yuhong Li.;Min Peng.;Xiaoqing Li.;Li Gao.;Rui'e Feng.;Yunzhi Zhou.;Juhong Shi.
来源: Chest. 2025年167卷6期e183-e188页
A 47-year-old woman initially presented with recurrent coughing caused by the ingestion of gritty foods such as nuts over 20 years ago. Subsequently, she experienced frequent postprandial episodes of white sputum containing food particles and suffered from acid reflux and heartburn, which were originally overlooked.

93. Spontaneous Resolution in Autoimmune Pulmonary Alveolar Proteinosis: A Case Series.

作者: Shrimukta Sahoo.;Puneet Saxena.;Akhil K Ravi.;Saurabh Tiwari.;Valliappan Muthu.;Ravi Charan Avala.;Vishwanath Gella.;Raghava Rao Gandra.;Robin Choudhary.
来源: Chest. 2025年167卷6期e177-e181页
Pulmonary alveolar proteinosis (PAP) is a rare lung condition characterized by the accumulation of proteinaceous material within the alveoli. The acquired form is often autoimmune, driven by autoantibodies against granulocyte-macrophage colony-stimulating factor. Presentation of autoimmune PAP may range from incidental detection in asymptomatic patients to advanced respiratory failure. Treatment typically involves whole lung lavage or granulocyte-macrophage colony-stimulating factor therapy in symptomatic patients; spontaneous resolution is rare in severe cases. Here, we report 3 cases of autoimmune PAP who presented with resting hypoxia and exhibited spontaneous resolution without significant treatment. All 3 cases had a history of occupational inhalational exposure to noxious gases, and they improved following sustained cessation of exposure. We hypothesize that occupational or environmental noxious inhalation exposure may have a role in disease expression in some cases of autoimmune PAP, and such cases may show spontaneous resolution following cessation of the offending exposure.

94. Usefulness of Cross-Lagged Panel Models for Clinical Research.

作者: Christophe Gauld.;Raoul P P P Grasman.;Sébastien Bailly.
来源: Chest. 2025年167卷6期1537-1540页

95. Conservative Management of Ground-Glass Nodules?: Yes, Please.

作者: Douglas A Arenberg.
来源: Chest. 2025年167卷6期1535-1536页

96. Treprostinil in Pulmonary Arterial Hypertension With Cardiovascular Comorbidities: To Use or Avoid.

作者: Jasleen K Minhas.;Nadine Al-Naamani.
来源: Chest. 2025年167卷6期1532-1534页

97. Conflicts of Interest in Interventional Pulmonary: Let's Shut the Door on Ambiguity.

作者: Yaron B Gesthalter.;Eric J Seeley.
来源: Chest. 2025年167卷6期1530-1531页

98. Noninvasive Ventilation for Cardiac Surgical Patients: Reducing Postoperative Complications.

作者: Elizabeth S Tetteh.
来源: Chest. 2025年167卷6期1528-1529页

99. "Fatty Muscle": The Hidden Player in Lung Function.

作者: Ming Yang.
来源: Chest. 2025年167卷6期1525-1527页

100. Pulmonary Rehabilitation in Interstitial Lung Disease: Improving How Patients Feel, Function-and Potentially Survive?

作者: Sabina A Guler.;Thomas F Riegler.
来源: Chest. 2025年167卷6期1523-1524页
共有 38350 条符合本次的查询结果, 用时 1.3775375 秒